Evaluating the safety profile of calcineurin inhibitors - cancer risk in patients with systemic lupus erythematosus from the LUNA registry - a historical cohort study
Favorite
Share
More Options
7

Open in WPS to view all 7 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
